Methoden vergleichen
Prüfen Sie die ausgewählten Methoden nebeneinander; abweichende Zeilen sind hervorgehoben.
| Mini-Mental State Examination× | Addenbrooke's Cognitive Examination× | |
|---|---|---|
| Fachgebiet | Neuropsychologie | Neuropsychologie |
| Familie | Process / pipeline | Process / pipeline |
| Entstehungsjahr≠ | 1975 | 2000 |
| Urheber≠ | Marshall Folstein | Padasalai Mathuranath |
| Typ≠ | Clinician-administered cognitive screening instrument | Clinician-administered comprehensive cognitive examination |
| Wegweisende Quelle≠ | Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). Mini-mental state: A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189-198. DOI ↗ | Mathuranath, P. S., Nestor, P. J., Berrios, G. E., Rakowicz, W., & Hodges, J. R. (2000). A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology, 55(11), 1613-1620. DOI ↗ |
| Aliasnamen≠ | MMSE, Folstein MMSE | ACE, ACE-R, ACE-III, Addenbrooke Cognitive Examination |
| Verwandt | 5 | 5 |
| Zusammenfassung≠ | The Mini-Mental State Examination (MMSE) is a brief, 30-point screening instrument developed by Folstein, Folstein, and McHugh in 1975 to assess cognitive function in clinical settings. It is designed to detect cognitive impairment and monitor cognitive decline over time, particularly in older adults and patients with suspected dementia. The MMSE remains one of the most widely used cognitive screening tools in primary care, neurology, and geriatric medicine worldwide. | The Addenbrooke's Cognitive Examination (ACE) is a brief yet comprehensive clinician-administered cognitive battery designed to assess multiple cognitive domains and differentiate between types of dementia. Originally developed by Mathuranath and colleagues at Cambridge University in 2000, the ACE was created to address limitations of single-domain screening tools. The revised version (ACE-R, 2006) and further refined version (ACE-III, 2013) provide updated norms and improved sensitivity. The ACE-R and ACE-III are particularly valuable for distinguishing Alzheimer's disease from frontotemporal dementia. |
| ScholarGateDatensatz ↗ |
|
|